By Gregory S. Porter | Published July 28, 2020 | Posted in Personal Injury | Tagged Tags: Cancer, Carcinogen, Drug, FDA Recall, Food and Drug Administration, N-nitrosodimethylamine, NDMA, Pharmaceuticals, Ranitidine, Zantac |
Heartburn Over Heartburn Pills? Making Sense of the Zantac© (Ranitidine) Recall by Amy S. York, Esq. Last fall, many heartburn sufferers were surprised when their local pharmacies started removing Zantac (ranitidine) and its generics from the shelves. People who had taken these medications for decades suddenly were left wondering what was happening, how could they Read More
Read More